Anthropic Secures $1.5B AI Venture Backed by Wall Street Giants, Shaking Software Sector 
Samsung Appoints New TV Business Head Amid Rising Competition from Chinese Rivals 
Berkshire Hathaway Meeting Sees Shift as Greg Abel Steps Into Leadership Spotlight 
GameStop Proposes $56 Billion eBay Acquisition in Bold Strategic Move 
Pinterest Stock Surges After Strong Q1 2026 Earnings Beat Expectations 
Regis Resources and Vault Minerals to Merge in $10.7B Gold Deal 
Anthropic’s $1.5B AI Venture with Wall Street Firms Targets Private Equity Market 
AMD Q1 Earnings Surge on AI Demand, Stock Jumps After Strong Guidance 
Novo Nordisk Raises 2026 Outlook on Strong Wegovy Demand 
Strategy Hints at Bitcoin Sales to Cover Dividends After Massive Q1 Loss 
Strategy Reports Q1 Loss as Bitcoin Holdings Trigger $14.46 Billion Unrealized Hit 
Middle East Conflict Impacts Australia and New Zealand Businesses 
Meta Plans $13B AI Data Center Financing in Texas Amid Surging Big Tech Investment 
Philips Reaffirms 2026 Outlook After Strong Q1 Sales and Margin Beat 
Volvo Car Sales Drop 10% in Early 2026 Despite Growth in Electric Vehicles 
Infineon Raises 2026 Outlook as AI Data Center Chip Demand Surges 
Continental AG Shares Jump After Q1 Profit Beats Expectations 
IRVINE, Calif., May 03, 2018 -- Evolus, Inc. (NASDAQ:EOLS) (“Evolus”), a lifestyle aesthetics company focused on delivering advanced aesthetic procedures and treatments to physicians and consumers, today announced that Murthy Simhambhatla, President and Chief Executive Officer is scheduled to present at the Bank of America Merrill Lynch 2018 Health Care Conference in Las Vegas, NV.
Event: Bank of America Merrill Lynch 2018 Health Care Conference
Date: Thursday, May 17, 2018
Time: 10:00 a.m. PT
Location: The Encore, Las Vegas, NV
An audio webcast of the Company’s presentation will be available on the investor relations section of Evolus’ website at www.Evolus.com. A replay of the webcast will be available for 90 days after the date of the presentation.
The Company will also be hosting one-on-one investor meetings at the conference on Wednesday, May 16. If interested in meeting with management, please reach out to Brian Johnston at [email protected] or your Bank of America Merrill Lynch contact.
About Evolus, Inc.
Evolus is a medical aesthetics company dedicated to bringing advanced aesthetic procedures and treatments to physicians and consumers. Evolus focuses on the self-pay aesthetic market and its lead product candidate DWP-450 (prabotulinumtoxinA), an injectable 900 kDa purified botulinum toxin type A complex.
Evolus Contacts:
Media:
Kirsten Thomas, The Ruth Group
Tel: +1-508-280-6592
Email: [email protected]
Investor Contact:
Brian Johnston, The Ruth Group
Tel: +1 646-536-7028
Email: [email protected]
